Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-042854

General Counsel sold 1,646 shares at $2.98 ($4,910)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-18 Sale : show line 1 in the form −1,646 $2.98 $4,910 383,816 D
Open-market sales · 1,646 sh · avg $2.98 · $4,910
Loading xslF345X05/form4.xml…